InspireMD (NSPR) Stock Statistics & Valuation Metrics

InspireMD has a market cap or net worth of $74.41M. The enterprise value is $62.35M.

InspireMD has 46,801,560 shares outstanding. The number of shares has decreased by -2.65% in one year.

InspireMD’s return on equity (ROE) is -0.88 and return on invested capital (ROIC) is -83.68%.

The current PE Ratio of InspireMD is ―. InspireMD’s PEG ratio is 0.00.

In the last 12 months, InspireMD had revenue of 8.98M and earned -48.79M in profits. Earnings per share was -0.76.

In the last 12 months, operating cash flow was -35.10M and capital expenditures -1.66M, giving a free cash flow of -36.77M billion.

InspireMD pays an annual dividend of ―, resulting in a dividend yield of ―

InspireMD upcoming earnings date is May 19, 2026, TBA (Confirmed).

InspireMD as a current ratio of 5.74, with Debt / Equity ratio of 4.03%

In the past 12 months, InspireMD has paid 63.00K in taxes.

InspireMD EV to EBITDA ratio is -2.55, with an EV/FCF ratio of -3.37.

InspireMD has $54.21M in cash and marketable securities with $2.22M in debt, giving a net cash position of $51.99M billion.

Gross margin is 29.50%, with operating margin of -546.97%, and net profit margin of -543.33%.

The average price target for InspireMD is $5.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy